BioSpace News Archive

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the full fiscal year ended December 31, 2021.

Stealth BioTherapeutics Corp (Nasdaq: MITO), announced today the presentation of new SBT-272 preclinical data at the Mitochondrial Biochemistry in Health and Disease Symposium in Breckenridge, CO and dosing of the first subject in its Phase 1 clinical trial of SBT-272.

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, reported financial results for the fourth quarter and year ended December 31, 2021.

CytoDyn Inc. announced that the U.S. Food and Drug Administration has placed a partial clinical hold on its HIV program and a full clinical hold on its COVID-19 program in the United States.

According to a new preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called ecopipam may have improved scores on tests of tic severity three months later.

Telix Pharmaceuticals Limited announces that Tiffany Olson has been appointed to the Board, as a U.S.-based independent, Non-Executive Director.

CStone Pharmaceuticals (“CStone”, HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the first patient has been enrolled in the U.S. in the Phase 1 clinical trial for CS5001.

Significant surge in geriatric population, in the last few years, has led to growing prevalence of SCAs.

Genetic testing is becoming more and more important day by day as it may reveal the potential health risks that general testing may not.

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported fourth quarter and full year 2021 financial results and provided a corporate update.